Modafinil for the treatment of multiple sclerosis-related fatigue

Annals of Pharmacotherapy

Volumn 44, Issue 6, 2010, Pages 1098-1103

  Brown, Jamie N ^a   Howard, Caroline A ^a   Kemp, Debra W ^a,b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b University of North Carolina at Chapel Hill   (United States)

Author keywords

Fatigue; Modafinil; Multiple sclerosis; Stimulants; Treatment

Indexed keywords

MODAFINIL; PLACEBO;

AGGRESSIVENESS; ANXIETY; ASTHENIA; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; DERMATITIS; DIARRHEA; DIZZINESS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; EPIGASTRIC PAIN; EXCITABILITY; FATIGUE; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; HYPERTENSION; INSOMNIA; MULTIPLE SCLEROSIS; NAUSEA; NERVOUSNESS; OFF LABEL DRUG USE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SYMPTOM; THORAX PAIN; VOMITING; XEROSTOMIA;

ANIMALS; BENZHYDRYL COMPOUNDS; FATIGUE; HUMANS; MULTIPLE SCLEROSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 77952948126     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M705     Document Type: Review

References (26)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000;343:938-952
2. Rosenberg JH, Shafor R. Fatigue in multiple sclerosis: a rational approach to evaluation and treatment. Curr Neurol Neurosci Rep 2005;5:140-146 (Pubitemid 40485490)
3. Zifko UA. Management of fatigue in patients with multiple sclerosis. Drugs 2004;64:1295-1304 (Pubitemid 38916343)
4. Freal JE, Kraft GH, Coryell JK. Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil 1984;65:135-138
5. Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and multiple sclerosis: evidence-based management strategies for fatigue and multiple sclerosis. Washington, DC: Paralyzed Veterans of America, 1998.
6. Bakshi R. Fatigue associated with multiple sclerosis: diagnosis, impact and management. Mult Scler 2003;9:219-227 (Pubitemid 36686688)
7. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol 1988;45:435-437
8. Kos D, Kerckhofs E, Nagels G, D'hooghe MB, Ilsbroukx S. Origin of fatigue in multiple sclerosis: review of the literature. Neurorehabil Neural Repair 2008;22:91-100.
9. Krupp LB. Fatigue in multiple sclerosis: definition, pathophysiology and treatment. CNS Drugs 2003;17:225-234 (Pubitemid 36390409)
10. Sharma KR, Kent-Braun J, Mynhier MA, Weiner MW, Miller RG. Evidence of abnormal intramuscular component of fatigue in multiple sclerosis. Muscle Nerve 1995;18:1403-1411
11. Krupp LB, Christodoulou C. Fatigue in multiple sclerosis. Curr Neurol Neurosci Rep 2001;1:294-298
12. Murray TJ. Amantadine therapy for fatigue in multiple sclerosis. Can J Neurol Sci 1985;12:251-254
13. Krupp LB, Coyle PK, Doscher C, et al. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline and placebo. Neurology 1995;45:1956-1961
14. The Canadian MS Research Group. A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis. Can J Neurol Sci 1987;14:273-278
15. Cohen RA, Fisher M. Amantadine treatment of fatigue associated with multiple sclerosis. Arch Neurol 1989;46:676-680 (Pubitemid 19150949)
16. Product Information. Provigil (modafinil). Frazer, PA: Cephalon, August 2007.
17. Kumar R. Approved and investigational uses of modafinil: an evidence-based review. Drugs 2008;68:1803-1839
18. Zifko UA, Rupp M, Schwarz S, Zipko HT, Maida EM. Modafinil in treatment of fatigue in multiple sclerosis: results of an open-label study. J Neurol 2002;249:983-987 (Pubitemid 35002216)
19. Nagels G, D'hooghe MB, Vleugels L, Kos D, Despontin M, De Deyn PP. P300 and treatment effect of modafinil on fatigue in multiple sclerosis. J Clin Neurosci 2007;14:33-40.
20. Brioshi A, Gramigna S, Werth E, et al. Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients. Eur Neurol 2009;63: 243-249
21. Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN. Efficacy and safety of modafinil for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Pyschiatry 2002;72:179-183 (Pubitemid 34102149)
22. Stankoff B, Waubant E, Confavreux C, et al; French Modafinil Study Group. Modafinil for fatigue in MS: a randomized, placebo-controlled double-blind study. Neurology 2005;64:1139-1143
23. Lange R, Volkmer M, Heesen C, Lipert J. Modafinil effects in multiple sclerosis patients with fatigue. J Neurol 2009;256:645-650
24. Kraft GH, Bowen J. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study (letter). Neurology 2005;65:1995-1997.
25. Rammohan KW, Lynn DJ. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study (letter). Neurology 2005;65:1995-1997.
26. Flachenecker P, Kümpfel T, Kallmann B, et al. Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler 2002;8:523-526 (Pubitemid 35396404)